As of 2025-04-22, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (18.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.35 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -5509.2%.
The range of the Relative Valuation is (15.64) - (21.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 14.0x | 11.8x |
| Forward P/E multiples | 9.5x - 13.0x | 11.2x |
| Fair Price | (15.64) - (21.40) | (18.93) |
| Upside | -4568.4% - -6214.7% | -5509.2% |
| Date | P/E |
| 2025-04-21 | -0.22 |
| 2025-04-17 | -0.21 |
| 2025-04-16 | -0.20 |
| 2025-04-15 | -0.21 |
| 2025-04-14 | -0.22 |
| 2025-04-11 | -0.20 |
| 2025-04-10 | -0.19 |
| 2025-04-09 | -0.21 |
| 2025-04-08 | -0.19 |
| 2025-04-07 | -0.21 |
| 2025-04-04 | -0.22 |
| 2025-04-03 | -0.24 |
| 2025-04-02 | -0.24 |
| 2025-04-01 | -0.23 |
| 2025-03-31 | -0.24 |
| 2025-03-28 | -0.26 |
| 2025-03-27 | -0.27 |
| 2025-03-26 | -0.27 |
| 2025-03-25 | -0.26 |
| 2025-03-24 | -0.27 |
| 2025-03-21 | -0.27 |
| 2025-03-20 | -0.27 |
| 2025-03-19 | -0.25 |
| 2025-03-18 | -0.25 |
| 2025-03-17 | -0.25 |
| 2025-03-14 | -0.25 |
| 2025-03-13 | -0.25 |
| 2025-03-12 | -0.24 |
| 2025-03-11 | -0.26 |
| 2025-03-10 | -0.25 |
| 2025-03-07 | -0.26 |
| 2025-03-06 | -0.27 |
| 2025-03-05 | -0.27 |
| 2025-03-04 | -0.27 |
| 2025-03-03 | -0.27 |
| 2025-02-28 | -0.29 |
| 2025-02-27 | -0.29 |
| 2025-02-26 | -0.28 |
| 2025-02-25 | -0.29 |
| 2025-02-24 | -0.30 |
| 2025-02-21 | -0.30 |
| 2025-02-20 | -0.31 |
| 2025-02-19 | -0.31 |
| 2025-02-18 | -0.30 |
| 2025-02-14 | -0.30 |
| 2025-02-13 | -0.30 |
| 2025-02-12 | -0.29 |
| 2025-02-11 | -0.28 |
| 2025-02-10 | -0.28 |
| 2025-02-07 | -0.29 |